en.Wedoany.com Reported - On June 24, the Office of the Science and Technology Committee of the Guangdong Provincial Committee of the Communist Party of China issued the "Guangdong Province Brain-Computer Interface Technology and Industry Collaborative Development Action Plan (2026-2030)", proposing to support Guangzhou in building a globally influential brain-computer interface (BCI) industry cluster. The action plan aims to establish a full-chain ecosystem of "technology-clinical-manufacturing-application", supporting the construction of the "Guangzhou Brain Valley" as a dual-core, multi-park BCI future industry pilot zone centered on Guangzhou's Haizhu and Tianhe districts, driving BCI from original innovation and technology development to industrial application.
The focus of building the "Guangzhou Brain Valley" is not merely the expansion of a single park, but the formation of multi-point linkages along the BCI industry chain. Guangdong encourages various districts in Guangzhou to formulate supporting special policies to attract professional institutions, innovative enterprises, and industrial service platforms for clustered development. Haizhu and Tianhe possess advantages in universities and research institutes, scientific research teams, clinical hospitals, industrial space, and a digital economy foundation, facilitating the integration of BCI research and development, clinical validation, product incubation, and application demonstration within the same urban industrial system.
The threshold for the BCI industry lies in interdisciplinary collaboration. Neural signal acquisition, EEG recognition, algorithmic decoding, chip components, medical device registration, clinical validation, and ethical governance all require long-term investment. Weakness in any single link can hinder technology from moving from the lab to the market. By proposing to strengthen industry-university-research-hospital-finance collaboration, Guangdong aims to connect universities, research institutes, high-level clinical hospitals, industrial capital, and corporate engineering capabilities, reducing gaps in the clinical translation and product deployment of scientific research achievements.
The development of non-invasive BCI systems is positioned as a key direction for Guangzhou. Compared to the invasive approach, non-invasive BCI typically does not require implanted devices, primarily identifying user intent through EEG, EMG, eye tracking, multimodal sensing, and other methods. Application scenarios cover rehabilitation training, status monitoring, assistive control, consumer electronics, intelligent interaction, and special operations. This approach is more accessible for consumer-grade applications and benchmark demonstration scenarios, making it more suitable for forming large-scale industrial exploration in the early stages.
Medical clinical demonstration is a crucial step for the BCI industry to mature. For BCI products to enter scenarios such as rehabilitation, neurological disease assessment, brain function monitoring, and clinical assisted therapy, they must undergo verification of safety, efficacy, stability, and ethical compliance. Guangdong's proposal to carry out scientific research clinical incubation and benchmark applications, as well as medical clinical demonstration and ethical standard construction, indicates that industrial development is not solely about increasing the number of enterprises, but also about simultaneously strengthening medical translation, regulatory alignment, and standard systems.
Consumer-grade applications and international innovation cooperation are also included in the action plan. In the future, BCI will not only serve medical rehabilitation but may also enter fields such as education and training, smart terminals, gaming and entertainment, virtual reality, industrial safety, and human-machine collaboration. For Guangzhou, if it can form a closed loop among non-invasive BCI, clinical demonstration, product incubation, and consumer-grade applications, it will have the opportunity to assume a clearer role in innovation origination and application transformation within Guangdong's future industrial system.
The action plan also sets targets: by 2027, Guangdong will achieve continuous breakthroughs in key BCI technologies, cultivate over 10 backbone enterprises in the industry chain, and initially form industrial clusters in Guangzhou and Shenzhen; by 2030, it aims to add 100 BCI technology-based enterprises, create over 10 blockbuster non-invasive BCI products, have multiple invasive BCI products enter clinical translation and obtain medical device registration certificates, achieve a core BCI industry scale of tens of billions of yuan, and drive the scale of upstream and downstream industries to hundreds of billions of yuan.
Guangdong's support for Guangzhou in building a BCI industry cluster indicates that BCI is transitioning from a cutting-edge technological concept into local industrial planning and urban cluster construction. The subsequent implementation effectiveness will depend on whether core components, data acquisition, algorithm platforms, clinical resources, medical device registration, and industrial capital can form continuous support. For Guangzhou, if the "Guangzhou Brain Valley" can successfully connect the technology, clinical, manufacturing, and application chains, it will become a crucial node in China's future BCI industrial layout.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
